Patents by Inventor Karl-Heinz Altmann

Karl-Heinz Altmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20150246907
    Abstract: Formula (1), X1 represents O or NR6, X2 represents O or NR6, X3 represents O or NR1, R1 represents H or C1 to C3 alkyl, R2 represents H, or linear or branched C1-C8 alkyl optionally including one or more heteroatoms, cyclopropyl, cyclobutyl, cyclohexyl or oxetanyl or amino acid side chain or protected amino acid side chain, or R1 and R2 may form together a saturated, partly saturated or unsaturated 5 or 6 membered ring system, optionally substituted, R3 represents H, cyclopentyl, cyclohexyl, aryl or hydroxyaryl, aryl or hydroxyaryl being optionally substituted by fluorine, or linear or branched C1 to C8 alkyl optionally including a hetero atom, R4 represents phenyl or 5- or 6-membered heterocycles including one or more nitrogen or oxygen atoms optionally substituted with 1 to 4, respectively 5 fluorine atoms, and R6 represents H, or linear or branched alkyl chain having 1 to 3 carbon atoms.
    Type: Application
    Filed: September 4, 2013
    Publication date: September 3, 2015
    Inventors: Karl-Heinz Altmann, Oliver Horlacher, Ruben Hartkoorn, Stewart Cole
  • Publication number: 20110009459
    Abstract: Epothilone derivatives of Formula (I) and their use as a pharmaceutical.
    Type: Application
    Filed: September 21, 2010
    Publication date: January 13, 2011
    Applicant: NOVARTIS AG
    Inventor: Karl-Heinz ALTMANN
  • Patent number: 7825141
    Abstract: Epothilone derivatives of Formula (I) and their use as a pharmaceutical.
    Type: Grant
    Filed: March 15, 2005
    Date of Patent: November 2, 2010
    Assignee: Novartis AG
    Inventor: Karl-Heinz Altmann
  • Publication number: 20100022596
    Abstract: The invention relates to analogues of epothilones, uses and methods of making the same.
    Type: Application
    Filed: December 12, 2007
    Publication date: January 28, 2010
    Inventor: Karl-Heinz Altmann
  • Publication number: 20090191264
    Abstract: This invention provides liposomal compositions comprising an epothilone.
    Type: Application
    Filed: April 3, 2009
    Publication date: July 30, 2009
    Inventors: Jean-Claude Sonntag, Markus Wartmann, Karl-Heinz Altmann
  • Publication number: 20080114040
    Abstract: Epothilone derivatives of Formula (I) and their use as a pharmaceutical.
    Type: Application
    Filed: March 15, 2005
    Publication date: May 15, 2008
    Applicant: NOVARTIS AG
    Inventor: Karl-Heinz Altmann
  • Patent number: 7358266
    Abstract: The invention relates to cis- and trans-12, 13-cyclopropyl and 12,13-cyclobutyl epothilones of formula I to IV wherein Ar is a radical represented by the following structure: and the other radicals and symbols have the meanings as defined herein; to their chemical synthesis and biological evaluation; their use in the treatment of neoplastic diseases and to pharmaceutical preparations containing such compounds. The compounds described herein are potent tubulin polymerization promoters and cytotoxic agents.
    Type: Grant
    Filed: August 23, 2002
    Date of Patent: April 15, 2008
    Assignee: The Scripps Research Institute
    Inventors: Kyriacos C. Nicolaou, Kenji Namoto, Andreas Ritzen, Mitsuru Shoji, Trond Ulven, Karl-Heinz Altmann
  • Publication number: 20060074112
    Abstract: Described are compunds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R1 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y?SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each, other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.
    Type: Application
    Filed: October 20, 2005
    Publication date: April 6, 2006
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul Manley, Jeanette Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Patent number: 7002022
    Abstract: Described are compunds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R2 is aryl; R2 is a mono- or bicyclic heteroaryl group comprising one or more ring nitrogen atoms with the exception that R2 cannot represent 2-phthalimidyl, and in case of Y=SO2 cannot represent 2,1,3-benzothiadiazol-4-yl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.
    Type: Grant
    Filed: April 21, 2004
    Date of Patent: February 21, 2006
    Assignees: Novartis AG, Schering Aktiengesellschaft
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jürgen Mestan, Andreas Huth, Martin Krüger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Publication number: 20050159374
    Abstract: The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I) The invention furthermore relates to nucleoside building blocks, intermediates and processes for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.
    Type: Application
    Filed: October 29, 2003
    Publication date: July 21, 2005
    Inventors: Bernard Cuenoud, Karl-Heinz Altmann, Pierre Martin, Heinz Moser
  • Patent number: 6878720
    Abstract: Described are compunds of formula (I), wherein W is O or S; X is NR8; Y is CR9R10—(CH2)n wherein R9 and R10 are independently of each other hydrogen or lower alkyl, and n is an integer of from and including 0 to and including 3; or Y is SO2; R1 is aryl; R2 is a bicyclic heteroaryl group comprising one ring nitrogen atom with the exception that R2 cannot represent 2-phthalimidyl; any of R3, R4, R5 and R6, independently of the other, is H or a substituent other than hydrogen; and R7 and R8, independently of each other, are H or lower alkyl; or a N-oxide or a pharmaceutically acceptable salt thereof for the preparation of a pharmaceutical product for the treatment of a neoplastic disease which responds to an inhibition of the VEGF receptor tyrosine kinase activity. The compounds of formula (I) can be used for the treatment e.g. of a neoplastic disease, such as a tumor disease, of retinopathy and age-related macular degeneration.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: April 12, 2005
    Assignees: Novartis AG, Schering Aktiengesellschaft
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jürgen Mestan, Andreas Huth, Martin Krüger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Publication number: 20050042275
    Abstract: The present invention provides pharmaceutical liposomal compositions comprising epothilones.
    Type: Application
    Filed: September 9, 2004
    Publication date: February 24, 2005
    Inventors: Jean-Claude Sonntag, Markus Wartmann, Karl-Heinz Altmann
  • Publication number: 20040198782
    Abstract: 1
    Type: Application
    Filed: April 21, 2004
    Publication date: October 7, 2004
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Patent number: 6710047
    Abstract: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etheritied or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, p
    Type: Grant
    Filed: January 7, 2003
    Date of Patent: March 23, 2004
    Assignee: Novartis AG
    Inventors: Guido Bold, Jörg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett, David Raymond Stover, Jeanette Marjorie Wood
  • Publication number: 20040039026
    Abstract: The invention relates to cis- and trans-12, 13-cyclopropyl and 12,13-cyclobutyl epothilones of formula I to IV 1
    Type: Application
    Filed: August 23, 2002
    Publication date: February 26, 2004
    Applicant: The Scripps Research Institute
    Inventors: Kyriacos C. Nicoloou, Kenji Namoto, Andreas Ritzen, Mitsuru Shoji, Trond Ulven, Karl-Heinz Altmann
  • Patent number: 6670468
    Abstract: The invention relates to an oligonucleotide derivative which comprises at least one nucleoside building block of the formula (I) The invention furthermore relates to nucleoside building blocks, intermediates and processes for preparing the oligonucleotide derivatives and the nucleoside building blocks. The invention also relates to pharmaceutical compositions and to uses of the oligonucleotide derivatives and the nucleoside building blocks.
    Type: Grant
    Filed: January 3, 2001
    Date of Patent: December 30, 2003
    Assignee: Novartis AG
    Inventors: Bernard Cuenoud, Karl-Heinz Altmann, Pierre Martin, Heinz Ernst Moser
  • Publication number: 20030191129
    Abstract: The invention relates to compounds of formula I, 1
    Type: Application
    Filed: January 7, 2003
    Publication date: October 9, 2003
    Inventors: Guido Bold, Jorg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett, David Raymond Stover, Jeanette Marjorie Wood
  • Patent number: 6608071
    Abstract: The invention relates to compounds of formula I wherein r is from 0 to 2; n is from 0 to 2; m is from 0 to 4; A, B, D and E are each independently of the others N or CH, with the proviso that not more than two of those radicals are N; G is lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa (—O—), thia (—S—) or imino (—NH—), or is lower alkylene substituted by acyloxy or by hydroxy; Q is lower alkyl, especially methyl; R is H or lower alkyl; X is imino, oxa or thia; Y is lower alkyl or, especially, aryl, heteroaryl or unsubstituted or substituted cycloalkyl; and Z is amino, mono- or di-substituted amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-di-substituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, phenyl-lower alkylthio, alkylphenylthio, phenylsulfinyl, phenyl-lowe
    Type: Grant
    Filed: February 9, 2001
    Date of Patent: August 19, 2003
    Assignee: Novartis AG
    Inventors: Karl-Heinz Altmann, Guido Bold, Paul William Manley
  • Publication number: 20030064992
    Abstract: 1
    Type: Application
    Filed: June 26, 2002
    Publication date: April 3, 2003
    Inventors: Karl-Heinz Altmann, Guido Bold, Pascal Furet, Paul William Manley, Jeanette Marjorie Wood, Stefano Ferrari, Francesco Hofmann, Jurgen Mestan, Andreas Huth, Martin Kruger, Dieter Seidelmann, Andreas Menrad, Martin Haberey, Karl-Heinz Thierauch
  • Patent number: 6514974
    Abstract: The invention relates to compounds of formula I, wherein r is 0 to 2, n is 0 to 2; m is 0 to 4; R1 and R2 (i) are in each case a lower alkyl, or (ii) together form a bridge in subformula I* or (iii) together form a bridge in subformula I** wherein one or two of the ring members T1, T2, T3, and T4 are nitrogen, and the remainder are in each case CH; A, B, D, and E are N or CH, wherein not more than 2 of these radicals are N; G is lower alkylene, acyloxy- or hydroxy-lower alkylene, —CH2—O—, —CH2—S—, —CH2—NH—, oxa, thia, or imino; Q is methyl; R is H or lower alkyl; X is imino, oxa, or thia; Y is aryl, pyridyl, or (un)substituted cycloalkyl; and Z is mono- or disubstited amino, halogen, alkyl, substituted alkyl, hydroxy, etherified or esterified hydroxy, nitro, cyano, carboxy, esterified carboxy, alkanoyl, carbamoyl, N-mono- or N,N-disubstituted carbamoyl, amidino, guanidino, mercapto, sulfo, phenylthio, p
    Type: Grant
    Filed: May 17, 2001
    Date of Patent: February 4, 2003
    Assignee: Novartis AG
    Inventors: Guido Bold, Jörg Frei, Peter Traxler, Karl-Heinz Altmann, Helmut Mett, David Raymond Stover, Jeanette Marjorie Wood